Janux Therapeutics, Inc. revenue breakdown overview

Janux Therapeutics, Inc. revenue for the last year amounted to 10.59 M USD, the most of which — 10.59 M USD — came from its highest performing source at the moment, Novel Immunotherapies, the year earlier bringing 8.08 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Janux Therapeutics, Inc. 10.59 M USD, and the year before that — 8.08 M USD.